Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes and renal impairment: the FIELD Study

Ting RD, Keech AC, Drury PL, Donoghoe MW, Hedley J, Jenkins AJ, Davis TM, Lehto S, Celermajer D, Simes RJ, Rajamani K, Stanton K; FIELD Study Investigators

(2012), Diabetes Care, 35(2), 218-25

Incidence and implications of negative serum thyroglobulin but positive I-131 whole-body scans in patients with well-differentiated thyroid cancer prepared with rhTSH or thyroid hormone withdrawal

Cherk MH, Francis P, Topliss DJ, Bailey M, Kalff V

(2012), Clin Endocrinol, 76(5), 734-40

Management of diabetes in patients with cystic fibrosis

Topliss D

(2011), Diabetes Management, 37, 28-9

Reducing potentially fatal errors associated with high doses of insulin: a successful multifaceted multidisciplinary prevention strategy

Dooley MJ, Wiseman M, McRae A, Murray D, Van De Vreede M, Topliss D, Poole SG, Wyatt S, Newnham H

(2011), BMJ Qual Saf, 20, 637-644

The history of the Endocrine Society of Australia. The first fifty years

Phillips DJ, Harding PE, Bach LA

(2011), Health Hist, 13(1), 90-106

Cardiac metastasis from thyroid carcinoma

Catford SR, Lee KT, Pace MD, Marasco SF, Longano A, Topliss DJ

(2011), Thyroid, 21(8), 855-66

Corticotropin-independent macronodular adrenal hyperplasia associated with insulinoma

Lee KT, Arnott RD, McLean CA, Serpell JW, Topliss DJ

(2011), Endocr Pract, 17(3), e43-7

Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy

Thallas-Bonke V, Coughlan MT, Bach LA, Cooper ME, Forbes JM

(2010), Am J Nephrol, 32(1), 73-82

Advanced glycation end products inhibit Na+ K+ ATPase in proximal tubule epithelial cells: role of cytosolic phospholipase A2alpha and phosphatidylinositol 4-phosphate 5-kinase gamma

Gallicchio MA, Bach LA

(2010), Biochim Biophys Acta-Mol Cell Res, 1803(8), 919-30

Cross-talk between MAP kinase pathways is involved in IGF-independent, IGFBP-6-induced Rh30 rhabdomyosarcoma cell migration

Fu P, Liang GJ, Khot SS, Phan R, Bach LA

(2010), J Cell Physiol, 224(3), 636-43

Insulin-like growth factor binding protein-6 (IGFBP-6) interacts with DNA-end binding protein Ku80 to regulate cell fate

Iosef C, Vilk G, Gkourasas T, Lee KJ, Chen BP, Fu P, Bach LA, Lajoie G, Gupta MB, Li SS, Han VK

(2010), Cell Signal, 22(7), 1033-43

Diagnostic characteristics of clozapine-induced myocarditis identified by an analysis of 38 cases and 47 controls

Ronaldson KJ, Taylor AJ, Fitzgerald PB, Topliss DJ, Elsik M, McNeil JJ

(2010), J Clin Psychiatry, 71(8), 976-81

The 4-mg intravenous dexamethasone suppression test in the diagnosis of Cushing's syndrome

Jung C, Alford FP, Topliss DJ, Burgess JR, Long F, Gome JJ, Stockigt JR, Inder WJ

(2010), Clin Endocrinol, 73(1), 78-84

Glycated proteins bind to ERM proteins and modulate their actions

Bach LA, Young A, Gallicchio MA, McRobert EA

(2010), In: Thomas MC, Forbes J (eds), Maillard Reaction: Interface between Aging, Nutrition and Metabolism, Royal Society of Chemistry, Cambridge, UK, 31-7

Cushing syndrome in a young woman due to primary pigmented nodular adrenal disease

Hackman KL, Davis AL, Curnow PA, Serpell JW, McLean CA, Topliss DJ

(2010), Endocr Pract, 16(1), 84-8

Recombinant human thyroid-stimulating hormone (Thyrogen) in thyroid cancer follow up: experience at a single institution

Wong R, Topliss DJ, Bach LA, Hamblin PS, Kalff V, Long F, Stockigt JR

(2009), Intern Med J, 39(3), 156-63

Medications that distort in vitro tests of thyroid function, with particular reference to estimates of serum free thyroxine

Stockigt JR, Lim CF

(2009), Best Pract Res Clin Endocrinol Metab, 23(6), 753-67

Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF)

Chapman I, Greville H, Ebeling PR, King SJ, Kotsimbos T, Nugent P, Player R, Topliss DJ, Warner J, Wilson JW

(2009), Clin Endocrinol, 70(6), 838-46

Diabetes and cystic fibrosis

Topliss DJ

(2008), Diabetes Manag J, 25, 10

Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention)

Origin Trial Investigators, Gerstein H, Yusuf S, Riddle MC, Ryden L, Bosch J

(2008), Am Heart J, 155(1), 26-32, 32.e1-6

7 8 9 10 11